CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of diseases with high unmet needs.
The company’s lead drug candidate is a clinical-stage, orally-administered small molecule (incyclinide / CMT-3 / COL-3) for the treatment of hospitalized sepsis patients at risk of septic shock, multiple organ dysfunction syndrome (MODS) and acute respiratory distress syndrome (ARDS), including from SARS-CoV-2 infection (COVID-19) and other infectious diseases.
Our clinical-stage drug candidate has already demonstrated impressive efficacy in a number of animal models of sepsis/ARDS/MODS across multiple species (rats, mice, pigs, sheep). It has also been evaluated in over 450 patients across eleven Phase I/II clinical studies, which showed that the drug is well-tolerated.
CMTx Biotech also has a pipeline of pre-clinical stage analogues for the treatment of diseases with high unmet need.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 25 Health Sciences Drive, Stony Brook,new York 11790,united States
- Phone
- 631 258 5680
- in****@****ech.com
- Industry
- Biotechnology
- Website
- http://www.cmtxbiotech.com
- Keywords
- Astravital Biotech.
- HQ
- Stony Brook, New York
Cmtx Biotech, Inc. Questions
Cmtx Biotech, Inc.'s helpline number is 631 258 5680
Cmtx Biotech, Inc.'s website is http://www.cmtxbiotech.com
Cmtx Biotech, Inc.'s LinkedIn profile is https://www.linkedin.com/company/cmtx-biotech-inc
Cmtx Biotech, Inc. has
7 employees.
View email and phone details for 7
employees at Cmtx Biotech, Inc..
Cmtx Biotech, Inc.'s industry is
Biotechnology
Cmtx Biotech, Inc.'s top competitors are
Astravital Biotech,
Traverse Biotech, Inc,
Biotech Without Borders,
Airfoil Corp,
Cynata Therapeutics,
Accutar Biotech,
Onethree Biotech,
Trotter Biotech Solutions,
Azure Biotech Inc.,
Ubique Biotech.
Cmtx Biotech, Inc.'s support email address is info@cmtxbiotech.com
Cmtx Biotech, Inc.'s categories are Biotechnology
Cmtx Biotech, Inc.'s founding year is 2019
